Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy

Supportive Care in Cancer

Volumn 9, Issue 6, 2001, Pages 469-470

  Kast, R E ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Anxiety control; Chemotherapy; Emesis control; Insomnia; Mirtazapine

Indexed keywords

ADRENERGIC RECEPTOR; BENZODIAZEPINE DERIVATIVE; HYDROCORTISONE; MIRTAZAPINE; ONDANSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR;

ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; HORMONE DEFICIENCY; HUMAN; INSOMNIA; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTINEOPLASTIC AGENTS; HUMANS; MIANSERIN; NAUSEA; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0034850145     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200000215     Document Type: Article

References (17)

1. Mirtazapine: A clinical overview
2. Mirtazapine: A review of its use in major depression
3. The pharmacologic profile of mirtazapine
4. Anti-emetic strategies for high dose chemoradiotherapy induced nausea and vomiting
5. 5HT-3 receptor antagonists for the prevention of chemotherapy induced nausea and vomiting
6. Antagonism of SSRI induced nausea by mirtazapine
7. Psychopharmacology in supportive care. I. Benzodiazapines
8. Effect of the antidepressant Org 3770 on human sleep
9. Cachexia and anorexia: Cancer's covert killer
10. Wasting in cancer
11. Depression in radiation oncology patients
12. Depression among cancer patients
13. Fatigue, depression, and quality of life; how are they related?
14. Depressive reactions to lung cancer are common and often followed by a poor outcome
15. Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer
16. Effects of mirtazapine on GH, prolactin and cortisol secretion in healthy male subjects
17. Mirtazapine and granulocytes - So far so good